Fluticasone Propionate and Salmeterol (Teva Pharmaceuticals USA, Inc.)


Welcome to the PulseAid listing for the Fluticasone Propionate and Salmeterol drug offered from Teva Pharmaceuticals USA, Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Pharmaceuticals USA, Inc.
NON-PROPRIETARY NAME: Fluticasone Propionate and Salmeterol
SUBSTANCE NAME: FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: POWDER, METERED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2017-04-20
END MARKETING DATE: 0000-00-00


Fluticasone Propionate and Salmeterol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFluticasone Propionate and Salmeterol from Teva Pharmaceuticals USA, Inc.
LABELER NAME: Teva Pharmaceuticals USA, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 55; 14(ug/1; ug/1)
START MARKETING DATE: 2017-04-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0093-3607_f99e48bc-787f-45a7-bf88-ab9a030fc02e
PRODUCT NDC: 0093-3607
APPLICATION NUMBER: NDA208799

Other FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline LLCADVAIR HFA
Teva Pharmaceuticals USA, Inc.Fluticasone Propionate and Salmeterol
Teva Respiratory, LLCAirDuo RespiClick